Mallinckrodt Initiates Rolling Submission of Biologics License Application for StrataGraft(R) Regenerative Skin Tissue to U.S. Food and Drug Administration

Application is Supported by Data from Pivotal Phase 3 Study for the Treatment of Deep Partial-Thickness Thermal Burns StrataGraft Skin Tissue Could be a Potential New Treatment Option for Deep Partial-Thickness Thermal Burns, if Approved STAINES-UPON... Regenerative Medicine, FDA Mallinckrodt, StrataGraft, regenerative tissue, burn wounds
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news